MP25-18 PURE TRANSABDOMINAL APPROACH FOR RENAL CELL CARCINOMA WITH SUPRADIAPHRAGMATIC TUMOR THROMBUS: A SINGLE-INSTITUTION INITIAL EXPERIENCE IN CHINA

Hai Bi,Guoliang Wang,Yi Huang,Lulin Ma
DOI: https://doi.org/10.1097/01.ju.0000555663.04204.65
2019-01-01
Abstract:You have accessJournal of UrologyKidney Cancer: Advanced (including Drug Therapy) II (MP25)1 Apr 2019MP25-18 PURE TRANSABDOMINAL APPROACH FOR RENAL CELL CARCINOMA WITH SUPRADIAPHRAGMATIC TUMOR THROMBUS: A SINGLE-INSTITUTION INITIAL EXPERIENCE IN CHINA Hai Bi*, Guoliang Wang, Yi Huang, and Lulin Ma Hai Bi*Hai Bi* More articles by this author , Guoliang WangGuoliang Wang More articles by this author , Yi HuangYi Huang More articles by this author , and Lulin MaLulin Ma More articles by this author View All Author Informationhttps://doi.org/10.1097/01.JU.0000555663.04204.65AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVES: Curative surgery is the only reasonable chance for the cure of renal cell carcinoma with supradiaphragmatic tumor thrombus. However, sternotomy, cardiopulmonary bypass (CBP) as well as deep hypothermic circulatory arrest (DHCA) significantly increased the chances of perioperative morbidity and mortality. Here, we described our modified surgical technique to remove the supradiapharagmatic tumor thrombus through an abdominal incision without sternotomy, CBP and DHCA, and investigated the safety and effective of this technique. METHODS: Between April 2015 and January 2018, we enrolled eight patients from our hospital, who underwent radical nephrectomy with removal of a level IV tumor thrombus through an abdominal incision using a transdiaphragmatic approach. Sternotomy, CBP and DHCA were not used. All clinical information, including patient demographics, operative variables and postoperative outcomes were retrospectively reviewed and analyzed. RESULTS: All patients were operated successfully without the use of sternotomy, CBP and DHCA. The median operative time was 7 hours 23.2 minutes. Median estimated blood loss was 2950mL. All patients received blood transfusion with median blood infusion of 2150mL. Two patients with Buddi-Chiari syndrome preoperative developed postoperative hydrothorax resulting from pleuro-abdominal fistula. All patients were alive at the last follow-up during a follow-up of 3.5 to 36 months. One patient experienced metastatic progression disease 1 year after surgery. CONCLUSIONS: Our experience revealed that this technique was effective and safety in selected patients with supradiaphragmatic tumor thrombus. However, patients with a large amount of ascitic fluid resulting from Buddi-Chiari syndrome should be alert to develop hydrothorax postoperatively resulting from pleuro-abdominal fistula. Source of Funding: none Beijing, China, People’s Republic of© 2019 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 201Issue Supplement 4April 2019Page: e350-e350 Advertisement Copyright & Permissions© 2019 by American Urological Association Education and Research, Inc.MetricsAuthor Information Hai Bi* More articles by this author Guoliang Wang More articles by this author Yi Huang More articles by this author Lulin Ma More articles by this author Expand All Advertisement PDF downloadLoading ...
What problem does this paper attempt to address?